Replies to post #233951 on Biotech Values

[DewDiligence]

Bearish take on INO data:

Among the 4 #COVID vaccines, fair to say $INO has the weakest viral challenge data despite much lower viral dose

- No sig difference in sgRNA in nasal swabs

- Unlike other vaccines, sgRNA was also detected in high number even in BAL -> No complete protection even in lungs https://t.co/6byrSPvh2O pic.twitter.com/P9vBiiugAz

— Andy Biotech (@AndyBiotech) July 30, 2020